Massachusetts-based Codman Neuro is preparing to take Asia Pacific by storm with new regulatory wins in China, South Korea and Taiwan for the company’s Revive SE thrombectomy device.
Results from a new study suggest that atrial fibrillation (AF) may pose a significant threat to patients undergoing surgery, especially those having non-cardiac procedures.
In an analysis of more than 1.7 million patients, researchers found that perioperative AF was associated with twice the risk of stroke in patients who had non-cardiac surgery. Patients who underwent a cardiac procedure saw a 30% increase in their stroke risk.
Israeli device maker Keystone Heart raised $14 million in a Series B funding round in support of its TriGaurd implant, designed to help protect the brain during transcatheter valve replacement procedures.
New clinical data continues to suggest that left atrial appendage occlusion devices may pose an improvement over warfarin drug regimens for treating patients at increased risk of stroke, researchers reported today.
Smartphone-based community ECG readings may help save lives as well as healthcare dollars, according to a study unveiled by mobile health company AliveCor.